The agency said it will work to develop multiple monoclonal antibodies, which help block a virus from infecting human cells.
Regeneron previously worked on a similar treatment for Ebola and MERS.
Read the full news release here.
More articles on pharmacy:
Walgreens pays $7.5M to resolve claims an employee impersonated a pharmacist
SwedishAmerican opens ScriptCenter, a self-serve pharmacy kiosk
Walgreens CEO talks strategy, skips buyout speculation at annual meeting
Register to Attend Webinar
Presenters:
James Germano, MD, Joint Reconstruction Specialist|Tim Tzimas, Innovative Sterilization Technologies
Next Up in Pharmacy
-
U.S. News & World Report released its pediatric Honor Roll Sept. 15, naming 11 children’s hospitals as the nation’s best.…
-
Outdated and unsaleable medications account for an estimated 1.5% of the nearly $700 billion annual U.S. pharmacy market, or approximately…
-
China and India together account for 90% of new active pharmaceutical ingredient drug master files submitted for U.S. medicines in…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
